NanoPalm

A spinoff from King Abdulaziz City for Science and Technology (KACST), NanoPalm is a biotech startup creating next-generation nanomedicines for affordable and accelerated pharmaceutical R&D activities. The company's main goal is to accelerate clinical trials in a cost-effective manner. Utilizing its next-gen lipid nanoparticles (NG-LNP), NanoPalm aims to develop effective Biorobots that ensure the success of drugs in gene therapy and clinical trials.
Sections Biotech
Key people 🧑🤝🧑
- Dr. Ali Alhasan - Co-founder & CEO
- Dr. Samar Alsudir - Co-founder & CTO
- Mr. Mustafa Aldreese - CFO
Highlights ⭐
Content in this section is available for DHArab Premium Members only. We manually enter this information so you can save time researching different companies.
Existing users 👉 click here to login
Looking to become a member? 👉 click here for more information
Last update:
January 21, 2024
Disclaimer: We cannot guarantee that the information on this page is 100% correct. more
